The FDA cleared RHA Dynamic Volume for midface augmentation and age-related volume loss, broadening Revance's dynamic-filler portfolio beyond the original RHA Collection indication for facial lines. Dynamic fillers — which retain movement and adapt to facial expression — have gained clinical traction as practitioners move away from overfilled, static results. RHA's mechanism (reverse crosslinking) is distinct from traditional HA fillers and appeals to patients seeking natural-looking correction.